Related Experiment Video
Updated: Dec 21, 2025

08:49
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.4K
Manipulating the TCR signaling network for cellular immunotherapy: Challenges & opportunities
Courtney A Matson1, Nevil J Singh1
1Department of Microbiology & Immunology, University of Maryland School of Medicine, 685 W Baltimore St, HSF1, Room 380, Baltimore, MD 21201, United States.
Molecular Immunology
|May 19, 2020
Summary
Targeting T cell receptor (TCR) signals offers a precise way to control T cell responses, improving therapies for infections and tumors. Understanding TCR signaling is key for developing next-generation treatments with fewer side effects.
Area of Science:
- Immunology
- Cellular Biology
- Biochemistry
Background:
- T cells are crucial for immunity against infections and tumors, but can also cause disease.
- T cell activation involves antigen recognition via the T cell receptor (TCR) and accessory signals.
- Current therapies often target broad regulators, leading to adverse events.
Purpose of the Study:
- To review recent advances in understanding T cell receptor (TCR) signaling.
- To highlight the role of TCR signals in T cell activation and differentiation.
- To explore how targeting TCR signals can improve therapeutic strategies.
Main Methods:
- Review of current scientific literature on TCR signaling pathways.
- Analysis of biochemical signaling networks coupled to the TCR.
- Discussion of recent advances in T cell activation and differentiation research.
Main Results:
- TCR signals play critical roles throughout T cell activation and differentiation.
- Targeting antigen-specific TCR signals allows for focused modulation of T cell responses.
- Understanding TCR signaling modalities and variant ligands is essential for therapeutic design.
Conclusions:
- Precisely targeting TCR signals holds potential for advanced therapeutic strategies.
- Next-generation pharmacologic and cellular therapies can benefit from TCR signal insights.
- This approach is particularly relevant for tumor immunotherapies and adoptive cell transfers.
Related Concept Videos
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
T Cell Activation and Clonal Selection
14.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.4K

